Answers are grounded in this paper and cite their sources.
The glymphatic system refers to cerebrospinal fluid-interstitial fluid exchange and proposed drainage pathways shaped by sleep, arousal, vascular dynamics, and astrocytic organization. This physiology offers a way to connect disturbances that often coexist in major depressive disorder (MDD): disrupted sleep, fatigue, cognitive slowing, and stress-related abnormalities. We propose that difficulty establishing or maintaining a coordinated sleep-astrocyte-vascular state may contribute to illness persistence in some patients. Treatment-resistant depression (TRD) provides a setting in which this possibility can be examined across the course of treatment. Preclinical studies link stress and depressive-like behavior to astrocytic injury, aquaporin-4 dysregulation, and altered fluid transport. Human imaging findings vary across depressive phenotypes. In a dedicated TRD study, a higher diffusion tensor imaging along the perivascular space (DTI-ALPS) ratio was partly driven by reduced denominator diffusivity, illustrating the importance of interpreting this indirect index at component level. Whole-brain spatiotemporal models provide a complementary account of the neural activity accompanying these physiological states. Ketamine/esketamine, transcranial magnetic stimulation, and chronobiological interventions offer different ways to investigate treatment-related change; serotonergic psychedelics provide an exploratory extension. Longitudinal studies can establish how changes in sleep, fluid-sensitive imaging, and neural dynamics relate temporally to clinical recovery. This Perspective therefore develops a potentially modifiable physiological dimension of persistent depressive illness and defines how it can be tested.
No takes yet. Share an insight, caveat, or question.
Barlattani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: